AMPH Operating Expenses

Amphastar Pharmaceuticals Inc · Operating Expenses

AMPH logo

AMPH Operating Expenses

Latest reported$233.82M
AMPH TTM Operating Expenses ($69.34M → $233.82M)
High-resolution chart · PNG

AMPH operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amphastar Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
233,823,000
224,388,000
215,654,000
207,094,000
178,661,000
174,304,000
165,626,000
166,282,000
157,114,000
153,007,000
154,134,000
145,310,000
144,867,000
147,558,000
141,363,000
140,009,000
131,141,000
129,424,000
129,852,000
131,823,000
138,400,000
137,683,000
132,386,000
132,058,000
131,915,000
127,230,000
131,962,000
131,481,000
125,343,000
122,942,000
115,846,000
104,945,000
101,696,000
97,245,000
94,333,000
96,561,000
94,915,000
91,623,000
88,166,000
82,367,000
81,874,000
84,108,000
84,039,000
84,273,000
82,546,000
75,026,000
68,798,000
66,471,000
66,924,000
66,447,000
69,339,000
68,610,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.